Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Efavirenz market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Efavirenzmarket, defines the market attractiveness level of Efavirenz market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Efavirenz industry, describes the types of Efavirenz market, the applications of major players and the market size, and deeply analyzes the current situation of the global Efavirenz market and the development prospects and opportunities of Efavirenz industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Efavirenz market in Chapter 13.
By Player:
Gilead Sciences
Mylan
Macleods Pharmaceuticals
Bristol-Myers Squibb
Cipla
Aurobindo Pharma
Teva
Hetero
Strides Pharma
By Type:
Single Efavirenz
Two-drug Combination
Three-drug Combination
By End-User:
Adults
Children
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Efavirenz Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Efavirenz Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Efavirenz Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Efavirenz Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Efavirenz Market Analysis and Outlook to 2022
-
7.1 Global Efavirenz Consumption (2017-2022)
-
7.2 United States Efavirenz Consumption (2017-2022)
-
7.3 Europe Efavirenz Consumption (2017-2022)
-
7.4 China Efavirenz Consumption (2017-2022)
-
7.5 Japan Efavirenz Consumption (2017-2022)
-
7.6 India Efavirenz Consumption (2017-2022)
-
7.7 South Korea Efavirenz Consumption (2017-2022)
8 Region and Country-wise Efavirenz Market Analysis and Outlook to 2028
-
8.1 Global Efavirenz Consumption Forecast (2022-2028)
-
8.2 United States Efavirenz Consumption Forecast (2022-2028)
-
8.3 Europe Efavirenz Consumption Forecast (2022-2028)
-
8.4 China Efavirenz Consumption Forecast (2022-2028)
-
8.5 Japan Efavirenz Consumption Forecast (2022-2028)
-
8.6 India Efavirenz Consumption Forecast (2022-2028)
-
8.7 South Korea Efavirenz Consumption Forecast (2022-2028)
9 Global Efavirenz Market Outlook by Types and Applications to 2022
-
9.1 Global Efavirenz Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Single Efavirenz Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Two-drug Combination Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Three-drug Combination Consumption and Growth Rate (2017-2022)
-
9.2 Global Efavirenz Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Children Consumption and Growth Rate (2017-2022)
10 Global Efavirenz Market Outlook by Types and Applications to 2028
-
10.1 Global Efavirenz Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Single Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Two-drug Combination Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Three-drug Combination Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Efavirenz Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)
11 Global Efavirenz Import and Export Analysis (Top 5 Countries)
-
11.1 Global Efavirenz Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Efavirenz Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Efavirenz Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Efavirenz Market Competitive Analysis
-
14.1 Gilead Sciences
-
14.1.1 Gilead Sciences Company Details
-
14.1.2 Gilead Sciences Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences Efavirenz Product and Service
-
14.2 Mylan
-
14.2.1 Mylan Company Details
-
14.2.2 Mylan Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mylan Efavirenz Product and Service
-
14.3 Macleods Pharmaceuticals
-
14.3.1 Macleods Pharmaceuticals Company Details
-
14.3.2 Macleods Pharmaceuticals Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Macleods Pharmaceuticals Efavirenz Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Efavirenz Product and Service
-
14.5 Cipla
-
14.5.1 Cipla Company Details
-
14.5.2 Cipla Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cipla Efavirenz Product and Service
-
14.6 Aurobindo Pharma
-
14.6.1 Aurobindo Pharma Company Details
-
14.6.2 Aurobindo Pharma Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aurobindo Pharma Efavirenz Product and Service
-
14.7 Teva
-
14.7.1 Teva Company Details
-
14.7.2 Teva Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Efavirenz Product and Service
-
14.8 Hetero
-
14.8.1 Hetero Company Details
-
14.8.2 Hetero Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Hetero Efavirenz Product and Service
-
14.9 Strides Pharma
-
14.9.1 Strides Pharma Company Details
-
14.9.2 Strides Pharma Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Strides Pharma Efavirenz Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Efavirenz
-
Figure Efavirenz Picture
-
Table Global Efavirenz Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Efavirenz Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Efavirenz Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Efavirenz Consumption by Country (2017-2022)
-
Figure United States Efavirenz Consumption and Growth Rate (2017-2022)
-
Table Europe Efavirenz Consumption and Growth Rate (2017-2022)
-
Figure China Efavirenz Consumption and Growth Rate (2017-2022)
-
Figure Japan Efavirenz Consumption and Growth Rate (2017-2022)
-
Figure India Efavirenz Consumption and Growth Rate (2017-2022)
-
Figure South Korea Efavirenz Consumption and Growth Rate (2017-2022)
-
Figure Global Efavirenz Consumption Forecast by Country (2022-2028)
-
Figure United States Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single Efavirenz Consumption and Growth Rate (2017-2022)
-
Figure Global Two-drug Combination Consumption and Growth Rate (2017-2022)
-
Figure Global Three-drug Combination Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Single Efavirenz Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Two-drug Combination Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Three-drug Combination Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Efavirenz Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Efavirenz Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Efavirenz Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Efavirenz Product and Service
-
Table Macleods Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Macleods Pharmaceuticals Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Macleods Pharmaceuticals Efavirenz Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Efavirenz Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Efavirenz Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Efavirenz Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Efavirenz Product and Service
-
Table Hetero (Foundation Year, Company Profile and etc.)
-
Table Hetero Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Efavirenz Product and Service
-
Table Strides Pharma (Foundation Year, Company Profile and etc.)
-
Table Strides Pharma Efavirenz Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strides Pharma Efavirenz Product and Service
-
